NAT-A exhibits anti-tumor activity against acquired epidermal growth factor receptor- tyrosine kinase inhibitor-resistant non-small cell lung cancer via inhibiting the
- DOI
- 10.1016/j.tranon.2026.103042
- Published
- 11
- Container
- Translational Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2026.103042,
title = {NAT-A exhibits anti-tumor activity against acquired epidermal growth factor receptor- tyrosine kinase inhibitor-resistant non-small cell lung cancer via inhibiting the},
author = {Liyun Liu and Xin Wang and Xinkai Wang and Li Guan and Yahui Liao and Qi He and Yanxi Sun and Ying Wu and Xiao Lin and Shuping Wang and Yongjun Zhou and Guohua Zhou and Weihua Jiao and Hou wen Lin and Fan Sun},
year = {2026},
journal = {Translational Oncology},
doi = {10.1016/j.tranon.2026.103042},
url = {https://doi.org/10.1016/j.tranon.2026.103042}
}RIS
TY - JOUR TI - NAT-A exhibits anti-tumor activity against acquired epidermal growth factor receptor- tyrosine kinase inhibitor-resistant non-small cell lung cancer via inhibiting the AU - Liyun Liu AU - Xin Wang AU - Xinkai Wang AU - Li Guan AU - Yahui Liao AU - Qi He AU - Yanxi Sun AU - Ying Wu AU - Xiao Lin AU - Shuping Wang AU - Yongjun Zhou AU - Guohua Zhou AU - Weihua Jiao AU - Hou wen Lin AU - Fan Sun PY - 2026 JO - Translational Oncology DO - 10.1016/j.tranon.2026.103042 UR - https://doi.org/10.1016/j.tranon.2026.103042 ER -
APA
Liu, L., Wang, X., Wang, X., Guan, L., Liao, Y., He, Q., Sun, Y., Wu, Y., Lin, X., Wang, S., Zhou, Y., Zhou, G., Jiao, W., Lin, H. W., & Sun, F. (2026). NAT-A exhibits anti-tumor activity against acquired epidermal growth factor receptor- tyrosine kinase inhibitor-resistant non-small cell lung cancer via inhibiting the. Translational Oncology. https://doi.org/10.1016/j.tranon.2026.103042
Source records
- doaj · retrieved 2026-09-26T22:06:08.146Z